Description
+ Include: 61 videos, size: 18.1 GB
+ Target Audience: practicing clinicians who diagnose and/or treat patients with pulmonary embolism
+ Sample video: contact me for sample video
+ Information:
The PERT Consortium was formed to promote best practices in Pulmonary Embolism (PE) care. By focusing solely on the entirety of PE – its etiology, pathophysiology, prevention, management approach, outcomes of specific treatments, and follow-up pathways – it is the intention of the Consortium to increase awareness of treatment options available to patients with PE, to reduce its incidence worldwide, to improve health outcomes, and to positively influence the impact of this terrible disease.
This annual 2 day, AMA PRA/ANCC‐accredited conference entitled, ”Pulmonary Embolism: What is Known, and What We Need to Know: A State of the Art and Scientific Update”, is designed for practicing clinicians who regularly care for patients with acute and chronic pulmonary embolism (PE), as well as those who are interested in studying the pathophysiology, epidemiology, diagnosis, prevention, medical and interventional management, novel treatment paradigms, and outcomes of pulmonary embolism (PE). The meeting agenda has been expanded to include topics and presentations surrounding COVID-19 and the unique association of this virus with Venous Thromboembolic Disease (VTE), and specifically its impact on incidence, diagnosis and unique management strategies of Pulmonary Embolism.
The annual PERT business meeting will take place on October 14th.
This two day course is designed to educate practicing clinicians who diagnose and/or treat patients with pulmonary embolism; academics and scientists who study pulmonary embolism.
Learning Objectives
At the conclusion of this activity, the participants will be able to:
- Discuss the epidemiology and pathophysiology of PE, including how to assess the risk of patients presenting with symptoms consistent with PE.
- Identify features that define low, intermediate and high‐risk PE
- Develop a diagnostic and treatment algorithm that incorporates risk stratification and meets the specific needs of patients presenting with signs and symptoms of PE.
- Appropriately select among various treatment options for intermediate‐ and high‐risk PE patients including: anticoagulation, fibrinolysis (intravenous and catheter‐directed), extra‐corporeal membrane oxygenation (ECMO), thrombectomy (suction and surgical), and IVC filter placement.
- Recognize the potential acute complications of PE and how to prevent and treat them.
- Develop algorithm to identify and manage long term consequences of PE, such as CTEPH and CTED; understand combination of pharmacologic and mechanical treatment options available for use in such patients.
- Describe unique patient populations with PE and their specific treatment challenges
- Discuss the benefits of a multidisciplinary approach to PE management, and how to implement a PE Response Team (PERT) in their hospital.
- Identify what constitutes high quality care for PE.
- Target opportunities for quality improvement at an institutional level.
- Address thrombosis issues related to COVID-19, specifically:
- Delineate the risk of thrombosis associated with COVID-19 infection
- Characterize the various manifestations and presentations of thrombosis and VTE seen with COVID-19, including the VITT syndrome
- Identify the proper testing pathways for COVID-19 associated clotting disorders
- Specify anticoagulation regimens currently utilized to treat active thrombosis, as well as the range of therapeutics available as prophylaxis to prevent recurrence in hospitalized patients.
- Delineate proper anticoagulation strategies for hospitalized COVID-19 patients
- Define proper anticoagulation for outpatients with active or convalescent infection
- Prescribe appropriate treatment/prophylaxis after discharge of COVID-19 patients
- Define the value and benefits of the multi-disciplinary approach in the management of PE and VTE, including the PERT approach
- Establish the role of PERT in COVID-19 patient, including adjustments in the treatment paradigms necessitated by active infection
+ Topics:
Acute PE Management Cardiopulmonary Bypass Technique to Support Percutaneous Treatment.mp4
Acute Pulmonary Embolism Clinical Evaluation and Biochemical Markers.mp4
Artificial Intelligence and Acute Pulmonary Embolism.mp4
Balloon Pulmonary Angioplasty for CTEPH PERT 2021.mp4
Bleeding Management and Use of Anticoagulants Panel Discussion.mp4
Bleeding Management Beyond Reversal.mp4
Bleeding Under UFH LMWH Fibrinolytics.mp4
COVID-19 Thromboprophylaxis and Treatment.mp4
Creating PERT Teams Workshop.mp4
CT Imaging Predictors of Oxygen Requirement at Discharge in Submassive Pulmonary Embolism.mp4
CTED vs CTEPH vs PTSD Unraveling the Gordian Knot.mp4
Diagnosis and Risk Stratification in PE Recent Guidelines and Impactful Papers.mp4
DOAC for Extended Duration Anticoagulation.mp4
DOAC-Associated Bleeding Management.mp4
ECHO and the Danger of Right Ventricle.mp4
ECMO and PE Indications, Contraindications, and Surgery.mp4
ECMO Cannulation for Acute Pulmonary Embolism.mp4
ECMO in PE Management and Ethics.mp4
Epidemiology of COVID-19 and Related Thrombosis.mp4
Global Impact of PE and Differences Between the US, Europe, Africa, and Asia.mp4
High Risk (Massive) Pulmonary Embolism Use of Systemic Thrombolysis and Mechanical Circulatory Support.mp4
Imaging Updates for Pulmonary Embolism Diagnosis CTA, MRA, Novel Contrast Agents and Spectral CT.mp4
Innovations in PE Management What Are the New Devices.mp4
Interventions for PE in 2021 Papers You Need to Know.mp4
IVC Filters Indications for the Use and Strategies for Their Removal.mp4
Management of Patients With Intermediate-Risk PE.mp4
Management of Patients With Low-Risk PE.mp4
Management of PE in 2021 How Early Can You Switch Patients With Acute Intermediate-Risk PE to Oral Anticoagulation.mp4
Management of PH With Medical Therapy, Balloon Angioplasty and Pulmonary Thromboendarterectomy Panel Discussion.mp4
Management of Tumor Thrombi.mp4
Mechanical Circulatory Support in Acute Pulmonary Embolism Device Options.mp4
Mechanical Circulatory Support in PE Workshop.mp4
New European Guidelines on Pulmonary Embolism What Has Changed and Why.mp4
Pathobiology and Medical Management of CTEPH Panel Discussion.mp4
Pathobiology of CTEPH What Are the Factors That Contribute to CTEPH.mp4
PE Diagnosis Panel Discussion.mp4
PE in the Ambulatory and Hospital Settings Scope of the Problem.mp4
PE-Tract Trial CDT or AC for Patients With Submassive PE.mp4
Pharmacotherapy in CTEPH Patients.mp4
POCUS in Pulmonary Embolism.mp4
Post PE Management Panel Discussion.mp4
Prevention of Cancer-Associated Thrombosis.mp4
Pulmonary Thromboendarterectomy for Chronic Pulmonary Thromboembolic Disease.mp4
Regulatory Pathways for Devices for Management of Pulmonary Embolism FDA Perspectives.mp4
Regulatory Pathways for PE Management Panel Discussion.mp4
Right Ventricular Failure and Pulmonary Infarction.mp4
Simultaneous Real-Time Intravascular Ultrasound Guided Transcatheter Pulmonary Embolectomy Improves Procedural Accuracy, Efficacy and Safety.mp4
STRIKE-PE Study Safety and Performance of the Aspiration System for the Treatment of Pulmonary Embolism.mp4
Survivorship After PE What to Follow and How to Follow Our Patients.mp4
The Clive Kearon Memorial Lecture.mp4
The FLAME Trial Mechanical Thrombectomy for Acute Massive Pulmonary Embolism.mp4
The Higher-Risk Pulmonary Embolism Thrombolysis Study (HI-PEITHO) Catheter-Directed Thrombolysis Vs Anticoagulation.mp4
The Regulatory Environment Affect on PE Patient Care Practicing Clinical’s Perspective.mp4
Thrombosis Management in COVID-19 Patients Panel Discussion.mp4
Trends and Outcomes of Acute Pulmonary Embolism Transfers A Nationwide Cohort Sample 2008-2018.mp4
Triaging Acute Pulmonary Embolism for Home Treatment or Simplified PESI Criteria The HOME-PE Randomized Trial.mp4
Updates on PERT Consortium Registry.mp4
Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT).mp4
VTE Prevention in Medical Patients.mp4
VTE Prevention in the Surgical Patient.mp4
VTE Prevention Panel Discussion.mp4
Reviews
There are no reviews yet.